The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Friedl-naderer Johanna since 2023.
This trader's CIK number is 1915598.
At the time of last reporting, Friedl-naderer Johanna was the Chief Commercial Officer of Dyne Therapeutics, Inc.. (stock ticker symbol DYN).
Also see all insider trading activities at Dyne Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | VIR | 0 | $0 | 1,482 | $33,819 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | DYN | 0 | $0 | 143 | $1,733 | 0 | $0 |
1. Vir Biotechnology, Inc. (VIR)
2. Dyne Therapeutics, Inc. (DYN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-03-03 | VIR | Sale | 1,482 | 22.82 | 33,819 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-13 | DYN | Sale | 143 | 12.12 | 1,733 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Friedl-naderer Johanna (Chief Commercial Officer of Dyne Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.